{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:08:32Z","timestamp":1791108512771,"version":"4.1.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T00:00:00Z","timestamp":1403827200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s11239-014-1091-4","type":"journal-article","created":{"date-parts":[[2014,6,26]],"date-time":"2014-06-26T11:33:16Z","timestamp":1403782396000},"page":"101-112","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Paclitaxel-eluting versus bare metal stents in primary PCI: a pooled patient-level meta-analysis of randomized trials"],"prefix":"10.1007","volume":"39","author":[{"given":"Giuseppe","family":"De Luca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurits T.","family":"Dirksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Kelb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Thuesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marteen A.","family":"Vink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Chechi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaia","family":"Spaziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Di Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Suryapranata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregg W.","family":"Stone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,6,27]]},"reference":[{"key":"1091_CR1","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ajem.2008.04.026","volume":"27","author":"G Luca De","year":"2009","unstructured":"De Luca G, Cassetti E, Marino P (2009) Percutaneous coronary intervention-related time delay, patient\u2019s risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction. Am J Emerg Med 27:712\u2013719","journal-title":"Am J Emerg Med"},{"key":"1091_CR2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.pcad.2007.11.004","volume":"50","author":"G Luca De","year":"2008","unstructured":"De Luca G, Suryapranata H, Marino P (2008) Reperfusion strategies in acute ST-elevation myocardial infarction: an overview of current status. Prog Cardiovasc Dis 50:352\u2013382","journal-title":"Prog Cardiovasc Dis"},{"key":"1091_CR3","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/j.1538-7836.2011.04513.x","volume":"9","author":"G Luca De","year":"2011","unstructured":"De Luca G, Bellandi F, Huber K, Noc M, Petronio AS, Arntz HR, Maioli M, Gabriel HM, Zorman S, DE Carlo M, Rakowski T, Gyongyosi M, Dudek D (2011) Early glycoprotein IIb\u2013IIIa inhibitors in primary angioplasty-abciximab long-term results (EGYPT-ALT) cooperation: individual patient\u2019s data meta-analysis. J Thromb Haemost 9:2361\u20132370","journal-title":"J Thromb Haemost"},{"key":"1091_CR4","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1160\/TH04-11-0726","volume":"93","author":"G Luca De","year":"2005","unstructured":"De Luca G, Smit JJ, Ernst N, Suryapranata H, Ottervanger JP, Hoorntje JC, Dambrink JH, Gosslink AT, de Boer MJ, van\u2019t Hof AW (2005) Impact of adjunctive tirofiban administration on myocardial perfusion and mortality in patients undergoing primary angioplasty for ST-segment elevation myocardial infarction. Thromb Haemost 93:820\u2013823","journal-title":"Thromb Haemost"},{"key":"1091_CR5","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","volume":"377","author":"GW Stone","year":"2011","unstructured":"Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, on behalf of the HORIZONS-AMI Trial Investigators et al (2011) Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial. Lancet 377:2193\u20132204","journal-title":"Lancet"},{"key":"1091_CR6","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1111\/j.1538-7836.2011.04445.x","volume":"9","author":"EP Navarese","year":"2011","unstructured":"Navarese EP, De Luca G, Castriota F, Kozinski M, Gurbel PA, Gibson CM, Andreotti F, Buffon A, Siller-Matula JM, Sukiennik A, De Servi S, Kubica J (2011) Low-molecular-weight heparins vs. unfractionated heparin in the setting of percutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis. J Thromb Haemost 9:1902\u20131915","journal-title":"J Thromb Haemost"},{"key":"1091_CR7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.amjcard.2007.03.076","volume":"100","author":"E Escolar","year":"2007","unstructured":"Escolar E, Mintz GS, Popma J, Michalek A, Kim SW, Mandinov L, Koglin J, Stone G, Ellis SG, Grube E, Dawkins KD, Weissman NJ (2007) Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). Am J Cardiol 100:621\u2013626","journal-title":"Am J Cardiol"},{"key":"1091_CR8","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.jcin.2011.03.005","volume":"4","author":"GW Stone","year":"2011","unstructured":"Stone GW, Ellis SG, Colombo A, Grube E, Popma JJ, Uchida T, Bleuit JS, Dawkins KD, Russell ME (2011) Long-term safety and efficacy of paclitaxel-eluting stents final 5-year analysis from the TAXUS Clinical Trial Program. JACC Cardiovasc Interv 4:530\u2013542","journal-title":"JACC Cardiovasc Interv"},{"key":"1091_CR9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/hrt.2005.061622","volume":"92","author":"C Roiron","year":"2006","unstructured":"Roiron C, Sanchez P, Bouzamondo A, Lechat P, Montalescot G (2006) Drug eluting stents: an updated meta-analysis of randomised controlled trials. Heart 92:641\u2013649","journal-title":"Heart"},{"key":"1091_CR10","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijcard.2007.12.040","volume":"133","author":"G Luca De","year":"2009","unstructured":"De Luca G, Stone GW, Suryapranata H, Laarman GJ, Menichelli M, Kaiser C et al (2009) Efficacy and safety of drug-eluting stents in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. Int J Cardiol 133:213\u2013222","journal-title":"Int J Cardiol"},{"key":"1091_CR11","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s11239-009-0305-7","volume":"28","author":"G Luca De","year":"2009","unstructured":"De Luca G, Valgimigli M, Spaulding C, Menichelli M, Brunner-La Rocca HP, van der Hoeven BL et al (2009) Short and long-term benefits of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized trials. J Thromb Thrombolysis 28:200\u2013210","journal-title":"J Thromb Thrombolysis"},{"key":"1091_CR12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00392-010-0133-y","volume":"99","author":"A Dibra","year":"2010","unstructured":"Dibra A, Tiroch K, Schulz S, Kelbaek H, Spaulding C, Laarman GJ et al (2010) A. Drug-eluting stents in acute myocardial infarction: updated meta-analysis of randomized trials. Clin Res Cardiol 99:345\u2013357","journal-title":"Clin Res Cardiol"},{"key":"1091_CR13","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(04)17275-9","volume":"364","author":"EP McFadden","year":"2004","unstructured":"McFadden EP, Stabile E, Regar E, Cheneau E, Ong AT, Kinnaird T et al (2004) Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 364:1519\u20131521","journal-title":"Lancet"},{"key":"1091_CR14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.293.17.2126","volume":"293","author":"I Iakovou","year":"2005","unstructured":"Iakovou I, Schmidt T, Bonizzoni E, Ge L, Sangiorgi GM, Stankovic G et al (2005) Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 293:2126\u20132130","journal-title":"JAMA"},{"key":"1091_CR15","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","volume":"113","author":"JA Spertus","year":"2006","unstructured":"Spertus JA, Kettelkamp R, Vance C, Decker C, Jones PG, Rumsfeld JS et al (2006) Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113:2803\u20132809","journal-title":"Circulation"},{"issue":"suppl 7A","key":"1091_CR16","first-page":"47H","volume":"96","author":"SJ Kernis","year":"2005","unstructured":"Kernis SJ, Cohen D, Rein K (2005) Clinical outcome associated with use of drug-eluting stents compared with bare metal stent for primary percutaneous intervention. Am J Cardiol 96(suppl 7A):47H","journal-title":"Am J Cardiol"},{"key":"1091_CR17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.amjcard.2006.11.070","volume":"99","author":"J Daemen","year":"2007","unstructured":"Daemen J, Tanimoto S, Garcia-Garcia HM, Kukreja N, van de Sande M, Sianos G et al (2007) Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries). Am J Cardiol 99:1027\u20131032","journal-title":"Am J Cardiol"},{"key":"1091_CR18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1136\/bmj.316.7124.61","volume":"31","author":"M Egger","year":"1998","unstructured":"Egger M, Smith GD (1998) Bias in location and selection of studies. BMJ 31:61\u201366","journal-title":"BMJ"},{"key":"1091_CR19","doi-asserted-by":"crossref","first-page":"W65","DOI":"10.7326\/0003-4819-151-4-200908180-00136","volume":"151","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. Ann Intern Med 151:W65\u2013W94","journal-title":"Ann Intern Med"},{"key":"1091_CR20","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.jcin.2010.11.003","volume":"4","author":"MA Vink","year":"2011","unstructured":"Vink MA, Dirksen MT, Suttorp MJ, Tijssen JG, van Etten J, Patterson MS et al (2011) 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial. JACC Cardiovasc Interv 4:24\u201329","journal-title":"JACC Cardiovasc Interv"},{"key":"1091_CR21","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ahj.2009.03.016","volume":"158","author":"E Lorenzo Di","year":"2009","unstructured":"Di Lorenzo E, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F et al (2009) Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the PaclitAxel or Sirolimus-Eluting stent vs bare metal stent in primary angiOplasty (PASEO) randomized trial. Am Heart J 158:e43\u2013e50","journal-title":"Am Heart J"},{"issue":"Suppl","key":"1091_CR22","first-page":"650","volume":"27","author":"U Pittl","year":"2006","unstructured":"Pittl U, Kaiser C, Brunner-La Rocca HP (2006) BASKET Investigators. Safety and efficacy of drug eluting stents versus bare metal stents in primary angioplasty of patients with acute ST-elevation myocardial infarction\u2014a prospective randomized study. Eur Heart J 27(Suppl):650 Abstract","journal-title":"Eur Heart J"},{"issue":"Suppl","key":"1091_CR23","first-page":"831","volume":"27","author":"G Sardella","year":"2006","unstructured":"Sardella G, Paroli M, Mancone M (2006) Impact of paclitaxel-eluting stent implantation in patients with STEMI on anti-inflammatory IL-10-producing T regulatory 1 (Tr1) cells. Eur Heart J 27(Suppl):831 Abstract","journal-title":"Eur Heart J"},{"key":"1091_CR24","unstructured":"Tierala I The Helsinki Area Acute Myocardial Infarction treatment re-evaluation\u2014Should the patient get a drug-eluting or a normal stent (HAAMU-STENT) study. http:\/\/www.tctmd.com\/csportal\/appmanager\/tctmd\/main?_nfpb=true&_pageLabel=TCTMDContent&hdCon=1453095 . Accessed 10 Oct 2013"},{"key":"1091_CR25","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1540-8183.2007.00270.x","volume":"20","author":"T Chechi","year":"2007","unstructured":"Chechi T, Vittori G, Biondi Zoccai GG, Vecchio S, Falchetti E, Spaziani G et al (2007) Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION). J Interv Cardiol 20:282\u2013291","journal-title":"J Interv Cardiol"},{"key":"1091_CR26","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jacc.2010.05.009","volume":"56","author":"A Kaltoft","year":"2010","unstructured":"Kaltoft A, Kelbaek H, Thuesen L, Lassen JF, Clemmensen P, Kl\u00f8vgaard L et al (2010) Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) Trial. J Am Coll Cardiol 56:641\u2013645","journal-title":"J Am Coll Cardiol"},{"key":"1091_CR27","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ahj.2005.06.047","volume":"151","author":"G Luca De","year":"2006","unstructured":"De Luca G, Ernst N, van\u2019t Hof AW, Ottervanger JP, Hoorntje JC, Gosselink AT, Dambrink JH, de Boer MJ, Suryapranata H (2006) Predictors and clinical implications of early reinfarction after primary angioplasty for ST-segment elevation myocardial infarction. Am Heart J 151:1256\u20131259","journal-title":"Am Heart J"},{"key":"1091_CR28","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1160\/TH13-02-0092","volume":"110","author":"G Luca De","year":"2013","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelb\u00e6k H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW (2013) DESERT cooperation. Time course, predictors and clinical implications of stent thrombosis following primary angioplasty. Insights from the DESERT cooperation. Thromb Haemost 110:826\u2013833","journal-title":"Thromb Haemost"},{"key":"1091_CR29","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0735-1097(93)90827-N","volume":"22","author":"BS George","year":"1993","unstructured":"George BS, Voorhees WD 3rd, Roubin GS, Fearnot NE, Pinkerton CA, Raizner AE et al (1993) Multicenter investigation of coronary stenting to treat acute or threatened closure after percutaneous transluminal coronary angioplasty: clinical and angiographic outcomes. J Am Coll Cardiol 22:135\u2013143","journal-title":"J Am Coll Cardiol"},{"key":"1091_CR30","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1056\/NEJM199604253341702","volume":"334","author":"A Schomig","year":"1996","unstructured":"Schomig A, Neumann FJ, Kastrati A, Schuhlen H, Blasini R, Hadamitzky M et al (1996) A randomised comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stents. N Engl J Med 334:1084\u20131089","journal-title":"N Engl J Med"},{"key":"1091_CR31","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.atherosclerosis.2012.02.041","volume":"222","author":"G Luca De","year":"2012","unstructured":"De Luca G, Verdoia M, Suryapranata H (2012) Benefits from intracoronary as compared to intravenous abciximab administration for STEMI patients undergoing primary angioplasty: a meta-analysis of 8 randomized trials. Atherosclerosis 222:426\u2013433","journal-title":"Atherosclerosis"},{"issue":"4","key":"1091_CR32","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/FJC.0000000000000052","volume":"63","author":"M Verdoia","year":"2014","unstructured":"Verdoia M, Schaffer A, Barbieri L, Cassetti E, Piccolo R, Galasso G, Marino P, Sinigaglia F, De Luca G (2014) Benefits from new ADP-antagonists as compared to clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: a meta-analysis of randomized trials. J Cardiovasc Pharmacol 63(4):339\u2013350","journal-title":"J Cardiovasc Pharmacol"},{"key":"1091_CR33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1160\/TH09-05-0287","volume":"102","author":"G Luca De","year":"2009","unstructured":"De Luca G, Cassetti E, Verdoia M, Marino P (2009) Bivalirudin as compared to unfractionated heparin among patients undergoing coronary angioplasty: a meta-analyis of randomised trials. Thromb Haemost 102:428\u2013436","journal-title":"Thromb Haemost"},{"key":"1091_CR34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/ccd.1204","volume":"53","author":"C Capozzolo","year":"2001","unstructured":"Capozzolo C, Piscione F, De Luca G, Cioppa A, Mazzarotto P, Leosco D, Golino P, Indolfi C, Chiariello M (2001) Direct coronary stenting: effect on coronary blood flow, immediate and late clinical results. Catheter Cardiovasc Interv 53:464\u2013473","journal-title":"Catheter Cardiovasc Interv"},{"issue":"1085","key":"1091_CR35","first-page":"e1","volume":"154","author":"G Luca De","year":"2007","unstructured":"De Luca G, Marino P (2007) Adjunctive benefits from low-molecular-weight heparins as compared to unfractionated heparin among patients with ST-segment elevation myocardial infarction treated with thrombolysis. A meta-analysis of the randomized trials. Am Heart J 154(1085):e1\u2013e6","journal-title":"Am Heart J"},{"key":"1091_CR36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.ijcard.2007.03.112","volume":"126","author":"G Luca De","year":"2008","unstructured":"De Luca G, Suryapranata H, Stone GW, Antoniucci D, Biondi-Zoccai G, Kastrati A, Chiariello M, Marino P (2008) Coronary stenting versus balloon angioplasty for acute myocardial infarction: a meta-regression analysis of randomized trials. Int J Cardiol 126:37\u201344","journal-title":"Int J Cardiol"},{"key":"1091_CR37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1136\/hrt.2004.056705","volume":"91","author":"H Suryapranata","year":"2005","unstructured":"Suryapranata H, De Luca G, Ottervanger JP, Hoorntje JC, Dambrink JH, Gosselink AT, Zijlstra F, de Boer MJ (2005) Is routine stenting for acute myocardial infarction superior to balloon angioplasty? A randomised comparison in a large cohort of unselected patients. Heart 91:641\u2013645","journal-title":"Heart"},{"key":"1091_CR38","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.amjcard.2013.03.012","volume":"112","author":"G Luca De","year":"2013","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelb\u00e6k H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW (2013) DESERT cooperation. Impact of age on long-term outcome after primary angioplasty with bare-metal or drug-eluting stent (from the DESERT cooperation). Am J Cardiol 112:181\u2013186","journal-title":"Am J Cardiol"},{"key":"1091_CR39","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11239-009-0420-5","volume":"30","author":"G Luca De","year":"2010","unstructured":"De Luca G, Sauro R, Varricchio A, Capasso M, Lanzillo T, Manganelli F, Mariello C, Siano F, Carbone G, Pagliuca MR, Rosato G, Di Lorenzo E (2010) Impact of diabetes on long-term outcome in STEMI patients undergoing primary angioplasty with glycoprotein IIb-IIIa inhibitors and BMS or DES. J Thromb Thrombolysis 30:133\u2013141","journal-title":"J Thromb Thrombolysis"},{"key":"1091_CR40","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.atherosclerosis.2009.03.042","volume":"207","author":"G Luca De","year":"2009","unstructured":"De Luca G, Gibson CM, Bellandi F, Noc M, Dudek D, Zeymer U, Arntz HR, Cutlip D, Maioli M, Zorman S, Mesquita Gabriel H, Emre A, Rakowski T, Gyongyosi M, Huber K, van\u2019t Hof AW (2009) Diabetes mellitus is associated with distal embolization, impaired myocardial perfusion, and higher mortality in patients with ST-segment elevation myocardial infarction treated with primary angioplasty and glycoprotein IIb-IIIa inhibitors. Atherosclerosis 207:181\u2013185","journal-title":"Atherosclerosis"},{"key":"1091_CR41","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.2337\/dc12-1507","volume":"36","author":"G Luca De","year":"2013","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelb\u00e6k H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, Diaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Suryapranata H, Stone GW (2013) DESERT cooperation. Impact of diabetes on long-term outcome after primary angioplasty: insights from the DESERT cooperation. Diabetes Care 36:1020\u20131025","journal-title":"Diabetes Care"},{"key":"1091_CR42","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","volume":"172","author":"G Luca De","year":"2012","unstructured":"De Luca G, Dirksen MT, Spaulding C, Kelbaek H, Schalij M, Thuesen L, van der Hoeven B, Vink MA, Kaiser C, Musto C, Chechi T, Spaziani G, D\u00edaz de la Llera LS, Pasceri V, Di Lorenzo E, Violini R, Cortese G, Suryapranata H, Stone GW (2012) Drug-eluting versus bare metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials. Arch Intern Med 172:611\u2013621","journal-title":"Arch Intern Med"},{"key":"1091_CR43","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1161\/CIRCULATIONAHA.106.687186","volume":"115","author":"GW Stone","year":"2007","unstructured":"Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE et al (2007) Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 115:2842\u20132847","journal-title":"Circulation"},{"key":"1091_CR44","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","volume":"380","author":"M Sabate","year":"2012","unstructured":"Sabate M, Cequier A, I\u00f1iguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, G\u00f3mez-Hospital JA, Baz JA, Martin-Yuste V, van Geuns RJ, Alfonso F, Bordes P, Tebaldi M, Masotti M, Silvestro A, Backx B, Brugaletta S, van Es GA, Serruys PW (2012) Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1\u00a0year results of a randomised controlled trial. Lancet 380:1482\u20131490","journal-title":"Lancet"},{"key":"1091_CR45","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","volume":"308","author":"L R\u00e4ber","year":"2012","unstructured":"R\u00e4ber L, Kelb\u00e6k H, Ostojic M, Baumbach A, Heg D, T\u00fcller D, von Birgelen C, Roffi M, Moschovitis A, Khattab AA, Wenaweser P, Bonvini R, Pedrazzini G, Kornowski R, Weber K, Trelle S, L\u00fcscher TF, Taniwaki M, Matter CM, Meier B, J\u00fcni P, Windecker S (2012) COMFORTABLE AMI Trial Investigators. Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: the COMFORTABLE AMI randomized trial. JAMA 308:777\u2013787","journal-title":"JAMA"},{"key":"1091_CR46","doi-asserted-by":"crossref","first-page":"985","DOI":"10.4244\/EIJV7I8A155","volume":"7","author":"EP Navarese","year":"2011","unstructured":"Navarese EP, Kubica J, Castriota F, Gibson CM, De Luca G, Buffon A, Bolognese L, Margheri M, Andreotti F, Di Mario C, De Servi S (2011) Safety and efficacy of biodegradable vs. durable polymer drug-eluting stents: evidence from a meta-analysis of randomised trials. EuroIntervention 7:985\u2013994","journal-title":"EuroIntervention"},{"key":"1091_CR47","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1056\/NEJMoa0706482","volume":"357","author":"SD Wiviott","year":"2007","unstructured":"Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S et al (2007) TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357:2001\u20132015","journal-title":"N Engl J Med"},{"key":"1091_CR48","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJMoa0904327","volume":"361","author":"L Wallentin","year":"2009","unstructured":"Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C et al (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361:1045\u20131057","journal-title":"N Engl J Med"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1091-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-014-1091-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-014-1091-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,11]],"date-time":"2019-08-11T23:11:08Z","timestamp":1565565068000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-014-1091-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,27]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["1091"],"URL":"https:\/\/doi.org\/10.1007\/s11239-014-1091-4","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,27]]}}}